price
CA
NASDAQ · CADL
Candel Therapeutics, Inc.
Healthcare · Biotechnology
$12.17
Down-$0.84 (-6.90%)
Updated Sep 11, 2026, 1:19 AM
SID Score
6.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 355.76M
- P/E ratio
- -30.96
- Dividend yield
- 0.00%
- 52-week range
- $4.44 – $14.00
- Volume
- 661.25K
- Avg. volume
- 778.62K
Price performance
CADL price history
1M range · 19 trading sessions · Daily adjusted prices
CADL closed at $12.17 after 19 trading sessions, up 3.14% for the selected period.
- Last close
- $12.17
- Period change
- +3.14%
- Period low
- $11.72
- Period high
- $13.75
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 9, 2026 | $12.52 | $12.78 | $12.13 | $12.17 | 661.25K |
| Sep 8, 2026 | $12.57 | $12.8458 | $12.02 | $12.60 | 1M |
| Sep 4, 2026 | $12.91 | $13.05 | $12.76 | $12.78 | 535.82K |
| Sep 3, 2026 | $13.21 | $13.28 | $12.73 | $12.97 | 628.31K |
| Sep 2, 2026 | $12.81 | $13.4099 | $12.6713 | $13.20 | 807.85K |
| Sep 1, 2026 | $12.93 | $13.035 | $12.602 | $12.85 | 935.64K |
| Aug 31, 2026 | $13.02 | $13.22 | $12.63 | $13.07 | 895.01K |
| Aug 28, 2026 | $13.635 | $13.7999 | $12.88 | $13.07 | 1.24M |
| Aug 27, 2026 | $13.26 | $14.00 | $13.20 | $13.75 | 1.19M |
| Aug 26, 2026 | $13.60 | $13.85 | $13.19 | $13.28 | 978K |
| Aug 25, 2026 | $13.09 | $13.95 | $12.9723 | $13.60 | 1.34M |
| Aug 24, 2026 | $12.99 | $12.99 | $12.40 | $12.86 | 959.09K |
| Aug 21, 2026 | $12.52 | $13.255 | $12.38 | $13.13 | 1.34M |
| Aug 20, 2026 | $13.23 | $13.38 | $12.33 | $12.35 | 1.54M |
| Aug 19, 2026 | $12.42 | $13.82 | $12.2795 | $13.50 | 2.38M |
| Aug 18, 2026 | $12.03 | $12.15 | $11.77 | $12.05 | 786.87K |
| Aug 17, 2026 | $11.49 | $12.485 | $11.11 | $12.16 | 2.16M |
| Aug 14, 2026 | $11.85 | $11.945 | $11.04 | $11.72 | 2.07M |
| Aug 13, 2026 | $10.85 | $11.87 | $10.475 | $11.80 | 2.15M |
Latest CADL news
The latest Smart Investors Daily articles mentioning CADL.
Stock researchCompany · Financials
Loading stock research…

